Sensor-Integrated Organ-on-a-Chip Platforms: Advances in Drug Evaluation and Disease Modeling
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c00932 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Sensors, 2026. Verfasst von Zhaofeng Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Optical Instrument and System, The Ministry of Education, Shanghai Engineering Research Center of Environmental Biosaf…. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices, Models, Biological, Drug Evaluation, Biosensing Techniques. Die Arbeit nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Organ-on-a-chip (OoC) platforms have made remarkable progress in simulating the physiological complexity of human tissues, and provide advanced in vitro models for drug development. These platforms offer superior physiological relevance over conventional cell culture and animal models and thus enhance preclinical drug testing. However, a key challenge is how to align the dynamics of these systems with analytical methods. The wide use of static endpoint assays can restrict the depth of obtainable mechanistic data, and often capture correlative results rather than the basic kinetic processes of a drug effect. This review probes into the premise that functional combination of sensors for real-time non-terminal detection is a critical trend for strengthening the analytical capability of OoC technology. Herein, this perspective is illustrated by systematically examining recent applications in drug toxicity evaluation and disease modeling. The discussion highlights how the focus of sensor-integrated platforms is shifting from physiological endpoint replication to dynamic mechanistic inquiry. These systems enable the continuous detection of key cellular and environmental indices, and thus provide high-resolution temporal data and a more detailed view of pharmacological responses. Finally, the current technological landscape, remaining challenges, and future outlook are summarized, positing that a further integration of sensing technologies is the key to exposing the full potential of OoCs for mechanistic and predictive drug assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Engineering Research Center of Optical Instrument and System, The Ministry of Education, Shanghai Engineering Research Center of Environmental Biosafety Instruments and Equipment, Shanghai Key Laboratory of Modern Optic…
- College of Medical, Veterinary & Life Sciences, University of Glasgow, GlasgowG12 8QQ, Scotland.
- Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong999077, Hong Kong SAR, China.
ORCID-Profile: Mengya Chen, Yule Zhang, Lulu Zheng
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Huang, Z., Zhang, Y., Li, F., Li, Y., Xue, Z., Chen, M., Li, J., Li, W., Zhang, Y., Zheng, L., & Zhuang, S. (2026). Sensor-Integrated Organ-on-a-Chip Platforms: Advances in Drug Evaluation and Disease Modeling. ACS Sensors. https://doi.org/10.1021/acssensors.6c00932
Vancouver
Huang Z, Zhang Y, Li F, Li Y, Xue Z, Chen M, et al. Sensor-Integrated Organ-on-a-Chip Platforms: Advances in Drug Evaluation and Disease Modeling. ACS Sensors. 2026. doi:10.1021/acssensors.6c00932
BibTeX
@article{Huang2026,
author = {Huang, Zhaofeng and Zhang, Yaohui and Li, Feiyang and Li, Yunxiao and Xue, Zhiwei and Chen, Mengya and Li, Junfei and Li, Wei and Zhang, Yule and Zheng, Lulu and Zhuang, Songlin},
title = {Sensor-Integrated Organ-on-a-Chip Platforms: Advances in Drug Evaluation and Disease Modeling},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c00932}
}
EUVIMED